Top Tweets for #CTAD20
.@AlzheimerEurope is organising an online meeting with @Nutricia. Tobias Hartmann is presenting results from the LipiDiDiet #clinicaltrial. Findings have recently been presented at #CTAD20 and published in Alzheimer's & Dementia.
For more information visit https://t.co/MWahroFIGc
For those attending #CTAD20: check out Poster 8, where we studied how #heterogeneity in #Alzheimers disease progression could influence trial outcomes. Spoiler: stratifying on risk factors for fast progression makes it more difficult to find an effect. @bettytijms @SietskeSikkes
Listening to #CTAD20 keynote from @OskarHansson9 on plasma biomarkers reminded me of this feature on our @Alzheimers_NIA website: https://t.co/RJIqQGdiEB
Don’t miss today’s keynote address at 11:30 am ET on the role of plasma biomarkers in the diagnosis and longitudinal follow-up of Alzheimer’s from Dr. @OskarHansson9 from @LundUniversity. #CTAD20
Remember to catch some of the great on-demand sessions! Today’s sessions include: the cognitive effects of aerobic exercise in Alzheimer’s Disease, the OC25 plasma fractions in Alzheimer’s Disease and many more. #CTAD20
We are pleased to present our latest @UsAgainstAlz research on the impact of agitation in #dementia this week at @CTADconference! #CTAD20
Agitation in #Alzheimers disease and dementia is associated with many negative outcomes, not least of which is #caregiver burden — including comorbidities such as insomnia and hypertension. UsA2's A-LIST research w/ @OtsukaUS explores these impacts: https://t.co/wfBgBrV2jg
Join our chat now on 3rd party validation of BrainSee, the first virtual microscope of the brain, at P15 in the #CTAD20 poster hall. New objective measures to improve #Alzheimers clinical trials #neuroscience
Meet us at P15 #CTAD20 send questions @netkaveh starting 1 am Eastern tomorrow -10 pm Pacific today! Thanks to investigators @Baycrest @CABHI__ @StanfordMed @UHN @GERAScentre @WUSTLmed and more
Tune in at 12 pm ET for a live panel discussion on the latest developments of a vaccine for the prevention and treatment of Alzheimer’s Disease led by Richard Mohs of @GAP_Foundation. #CTAD20
#CTAD20 Keynote from @ApostolovaLiana “The LEADS Program: a new opportunity for therapeutic research.” An @Alzheimers_NIH -funded consortium, LEADS will gather data to understand how and why approximately 5% of people with Alzheimer's disease develop symptoms before age 65.
Congratulations to our Chief Science Officer @DrMariaALZ, one of the most respected voices in the Alzheimer’s research community, on receiving the @CTADconference 2020 Lifetime Achievement Award in Alzheimer's Disease Therapeutic Research. #ENDALZ #CTAD20 https://t.co/sjGXWdYeT0
Today marks the first day of #CTAD20! We are looking forward to a thought-provoking next few days on new advances in #Alzheimers research and #clinicaltrials. CC @CTADconference
Congrats to @DrMariaALZ from the @alzassociation on her CTAD Lifetime Achievement Award in recognition for her extensive contributions to the advancement of AD clinical trials. #CTAD20
Welcome to #CTAD20! This year’s conference may be digital, but there are still plenty of can’t miss sessions, panel discussions, symposiums and much more. Visit https://t.co/rnetqCV45w for today’s schedule.
Meet us at P15 #CTAD20 send questions @netkaveh starting 1 am Eastern tomorrow -10 pm Pacific today! Thanks to investigators @Baycrest @CABHI__ @StanfordMed @UHN @GERAScentre @WUSTLmed and more
At #CTAD20 find our brain mapping poster: Validation of a novel technology for non-invasive prognosis of amnestic MCI in clinics and clinical trials at 1 pm EST November 4 - @netkaveh @Kamalizare presenting BrainSee
$AXSM para presentar datos del ensayo ADVANCE-1 de AXS-05 en la agitación de la enfermedad de Alzheimer en #CTAD20
$AXSM to Present Data from the ADVANCE-1 Trial of AXS-05 in Alzheimer’s Disease Agitation at #CTAD20
Next week marks the start of #CTAD20, hosted by @CTADconference. We’re proud to join virtually & share the latest in research and scientific advances for Alzheimer’s disease.
At #CTAD20 find our brain mapping poster: Validation of a novel technology for non-invasive prognosis of amnestic MCI in clinics and clinical trials at 1 pm EST November 4 - @netkaveh @Kamalizare presenting BrainSee
Symposium 1: Development of a Vaccine for Prevention and Treatment of Alzheimer’s disease will be Live @CTADconference on November 4 at noon US EST @DrJeffCummings @BannerHealth
Last Seen Hashtags on Sotwe
futa sarada
Seen from Italy
sweetiefox video
Seen from Pakistan
สาวใหญ่
Seen from Canada
Osundecides
Seen from United States
รับงานนราธิวาส
Seen from Thailand
brosis() filter:videos
Seen from United States
直男体育生
Seen from Singapore
espiadas #vestidores
Seen from Peru
zoo #sex
Seen from Malaysia
girlsfinishingthejob
Seen from Oman
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.3M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
83.9M followers
Lady Gaga
@ladygaga
75.4M followers
Virat Kohli
@imvkohli
73.3M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.3M followers
Bill Gates
@billgates
65.1M followers
Selena Gomez
@selenagomez
63M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers